Amity Frede

658 total citations
13 papers, 472 citations indexed

About

Amity Frede is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Amity Frede has authored 13 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Genetics and 9 papers in Rheumatology. Recurrent topics in Amity Frede's work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Eosinophilic Disorders and Syndromes (9 papers). Amity Frede is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Eosinophilic Disorders and Syndromes (9 papers). Amity Frede collaborates with scholars based in Australia, Italy and Switzerland. Amity Frede's co-authors include Timothy P. Hughes, Deborah L. White, Verity A Saunders, Phuong Dang, Stephanie Zrim, Paul W. Manley, Jane R. Engler, Michael Osborn, Devendra Hiwase and Sharad Kumar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Amity Frede

13 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amity Frede Australia 8 396 323 174 123 58 13 472
D. W. Kim United States 8 507 1.3× 411 1.3× 261 1.5× 124 1.0× 67 1.2× 9 592
Nataliia Glushko Ukraine 2 275 0.7× 217 0.7× 120 0.7× 77 0.6× 42 0.7× 2 327
Allison Jeynes-Ellis United States 4 282 0.7× 224 0.7× 124 0.7× 79 0.6× 47 0.8× 5 400
Barbara Scappini Italy 15 395 1.0× 242 0.7× 119 0.7× 110 0.9× 187 3.2× 42 578
Hyacinthe Johnson‐Ansah France 9 353 0.9× 293 0.9× 161 0.9× 90 0.7× 31 0.5× 18 414
Giovanna Rege Cambrin Italy 13 518 1.3× 405 1.3× 191 1.1× 58 0.5× 110 1.9× 28 609
Gioia Colafigli Italy 11 270 0.7× 178 0.6× 61 0.4× 54 0.4× 99 1.7× 41 333
Fabian Lang Germany 8 227 0.6× 164 0.5× 69 0.4× 53 0.4× 67 1.2× 39 285
Uwe Schwindel Germany 4 279 0.7× 238 0.7× 157 0.9× 30 0.2× 48 0.8× 4 345
A. Megan Cornelison United States 9 246 0.6× 144 0.4× 55 0.3× 52 0.4× 92 1.6× 16 324

Countries citing papers authored by Amity Frede

Since Specialization
Citations

This map shows the geographic impact of Amity Frede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amity Frede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amity Frede more than expected).

Fields of papers citing papers by Amity Frede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amity Frede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amity Frede. The network helps show where Amity Frede may publish in the future.

Co-authorship network of co-authors of Amity Frede

This figure shows the co-authorship network connecting the top 25 collaborators of Amity Frede. A scholar is included among the top collaborators of Amity Frede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amity Frede. Amity Frede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hughes, Timothy P., Chung Hoow Kok, Verity A Saunders, et al.. (2012). Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells. British Journal of Cancer. 106(11). 1772–1778. 18 indexed citations
2.
3.
4.
Hiwase, Devendra, Deborah L. White, Jason A. Powell, et al.. (2010). Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors. Leukemia. 24(4). 771–778. 37 indexed citations
5.
Engler, Jane R., Amity Frede, Verity A Saunders, et al.. (2010). The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34+ cells. Blood. 116(15). 2776–2778. 19 indexed citations
6.
7.
Frede, Amity, et al.. (2010). Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity. Leukemia. 24(4). 765–770. 48 indexed citations
8.
White, Deborah L., Phuong Dang, Jane R. Engler, et al.. (2010). Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib. Journal of Clinical Oncology. 28(16). 2761–2767. 132 indexed citations
9.
White, Deborah L., Verity A Saunders, Amity Frede, et al.. (2009). The Functional Activity of the OCT-1 Protein Is Predictive of Molecular Response and Survival in CP-CML Patients Treated with Imatinib: A 5 Year Update of the TIDEL Trial.. Blood. 114(22). 507–507. 2 indexed citations
10.
Hiwase, Devendra, Verity A Saunders, D. Hewett, et al.. (2008). Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications. Clinical Cancer Research. 14(12). 3881–3888. 154 indexed citations
11.
12.
Engler, Jane R., Amity Frede, Andrew C.W. Zannettino, Deborah L. White, & Timothy P. Hughes. (2008). Reduced Activity of the OCT-1 Protein in Primitive CML Cells: A Likely Determinant of Stem Cell Resistance in Imatinib Treated CML Patients. Blood. 112(11). 196–196. 2 indexed citations
13.
White, Deborah L., Phuong Dang, Amity Frede, et al.. (2008). Enhancing the Functional Activity of the OCT-1 Influx Pump May Overcome the Negative Impact of Low OCT-1 Activity in Imatinib Treated CML Patients. Blood. 112(11). 723–723. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. W. Kim Breakdown of academic impact, for papers by Nataliia Glushko Breakdown of academic impact, for papers by Allison Jeynes-Ellis Breakdown of academic impact, for papers by Barbara Scappini Breakdown of academic impact, for papers by Hyacinthe Johnson‐Ansah Breakdown of academic impact, for papers by Giovanna Rege Cambrin Breakdown of academic impact, for papers by Gioia Colafigli Breakdown of academic impact, for papers by Fabian Lang Breakdown of academic impact, for papers by Uwe Schwindel Breakdown of academic impact, for papers by A. Megan Cornelison
Rankless by CCL
2026